Epitope-targeted cytotoxic T cells mediate lineage-specific antitumor efficacy induced by the cancer mucosa antigen GUCY2C
AE Snook, MS Magee, GP Marszalowicz… - Cancer Immunology …, 2012 - Springer
Abstract Guanylyl cyclase C (GUCY2C) is the index cancer mucosa antigen, an emerging
class of immunotherapeutic targets for the prevention of recurrent metastases originating in …
class of immunotherapeutic targets for the prevention of recurrent metastases originating in …
[PDF][PDF] Tumour vaccines, monoclonals, proteins or whole cell therapies
S Boghossian, A Von-Delwig - J Vaccines Vaccin, 2012 - researchgate.net
Immunotherapy has dramatically changed the outcome of many tumours. Whether it is by
using antibodies as a humoral form of tumour control and clearance or active vaccines that …
using antibodies as a humoral form of tumour control and clearance or active vaccines that …